CARLSBAD, Calif.,
'We are very pleased to add an executive of Brad's caliber to our
management team,' said
'We would like to thank Howard for his contributions to the Company over
the past two years. Howard was brought on board to assist iVOW with the
transition from a technology company to a pure-play services business, the
implementation of our new business model, the raising of additional capital,
and the reduction of our cost structure. Howard was instrumental in helping
us make good progress on all of these initiatives, and we wish him well in his
future endeavors,' said
iVOW, inc.
Our business is focused exclusively on the disease state management of chronic and morbid obesity. We provide program management, operational consulting and clinical training services to physicians and hospitals involved in the medical and surgical treatment of morbidly obese patients. We also provide specialized vitamins to patients who have undergone obesity surgery. Our corporate website is www.ivow.com; information on our nutritional supplements for post-surgical gastric bypass patients may be found on www.vistavitamins.com. iVOW is the new corporate name of Vista Medical Technologies, Inc. iVOW is traded on the NASDAQ SmallCap Market under the stock symbol IVOW.
Forward Looking Statements
This news release may contain forward-looking statements concerning the
business and products of Vista Medical. Actual results may differ materially
depending on a number of risk factors, including, but not limited to the
following: the Company's efforts to attain the continued listing requirement
for Stockholders' Equity on the Nasdaq stock exchange; the success of the
Company's appeal to the Nasdaq Listing Qualifications Panel; the Company's
ability to raise additional capital to fund our operations and execute our
business plan; the Company's ability to penetrate the market for obesity
surgery management services; customer acceptance of our products and services.
Other risks inherent in our business are described in our Securities and
Exchange Commission filings, including our Annual Report on Form 10-K/A for
the year ended
FOR FURTHER INFORMATION
AT iVOW: AT FINANCIAL RELATIONS BOARD:
Michael H. Owens, MD,MPH,FACPE,CPE Tony Rossi
President & CEO Media Contact
mowens@ivow.com trossi@financialrelationsboard.com
(760) 603-9120 (310) 854-8317
SOURCE iVOW




